NHLBI Research Initiatives

From time to time, the NHLBI invites investigators to submit grant applications or contract proposals for specific research programs. We are currently soliciting applications for the programs described below. Unless a due date is mentioned, applications are accepted for February 1, June 1, and October 1 deadlines each year. For full details of these and other research initiatives, visit www.nhlbi.nih.gov/funding/inits/index.htm or the Web page that is linked each initiative number.

Anemia in the Elderly

• Initiative Number: RFA AG-06-002
• Applications due: January 20, 2006
• Objective: To explore the epidemiology, pathophysiology, and clinical aspects of anemia in the elderly.

Cardiovascular Cell Therapy Research Network

• Initiative Number: RFA HL-06-001
• Applications due: March 10, 2006
• Objective: To establish a network to conduct multiple, collaborative, proof-of-concept, cell therapy clinical protocols to enhance the repair and regeneration of damaged cardiovascular tissue.

Clinical Hematology Research Career Development Program (K12)

• Initiative Number: RFA HL-06-006
• Applications due: February 14, 2006
• Objective: To develop multidisciplinary career development programs in non-malignant clinical hematology research in order to equip new academic researchers with the knowledge and skills necessary to address complex problems in blood disease, transfusion medicine, and cellular therapies.

Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and Alaska Natives

• Initiative Number: RFA HL-06-002
• Applications due: March 10, 2006
• Objective: To test the effectiveness of behavioral interventions such as weight reduction, regular physical activity, and smoking cessation to reduce the risk of cardiovascular disease in American Indians and Alaska Natives.

Genomics and Proteomics: Short Courses on Applications to Complex Heart, Lung, Blood, and Sleep Disorders

• Initiative Number: RFA HL-05-012
• Applications due: January 17, 2006
• Objective: To develop, conduct, evaluate, and disseminate short-term courses on the application of genomics to heart, lung, blood, and sleep disorders.

Long-Term Oxygen Treatment Trial

• Initiative Number: RFP HR-06-07
• Applications due: January 24, 2006
• Objective: To determine the efficacy of continuous long-term oxygen treatment for improving survival in subjects with chronic obstructive pulmonary disease and less-than-severe hypoxemia at rest.

Obese and Diabetic Intrauterine Environment: Long-Term Metabolic or Cardiovascular Consequences in the Offspring

• Initiative Number: RFA DK-05-014
• Applications due: March 16, 2006
• Objective: To investigate the effect of maternal obesity and diabetes on mechanisms that could potentially contribute to obesity, metabolic disease, and cardiovascular disease in the offspring.

RNA Interference (RNAi): Stability, Delivery, and Processing by Tissues

• Initiative Number: RFA HL-05-019
• Applications due: January 18, 2006
• Objective: To increase our understanding of the biology of RNA interference, an effective post-transcriptional strategy for silencing genes, in order to develop its therapeutic potential for a wide range of heart, lung, and blood diseases.

Short Sleep Duration and Risk of Obesity or Overweight: Linking Mechanisms

• Initiative Number: RFA HL-06-03
• Applications due: January 25, 2006
• Objective: To investigate whether metabolic and appetite changes resulting from short sleep duration contribute to weight gain.

Systems Biology Exploratory Program

• Initiative Number: RFA HL-06-004
• Applications due: March 10, 2006
• Objective: To undertake a coordinated "systems biology" approach to understanding the normal physiology and perturbations associated with heart, lung, blood, and sleep disorders in order to develop new high-impact treatments and prevention strategies.

Type I Diabetes and its Complications: Development of New Therapeutics and Monitoring Technologies (SBIR/STTR)

• Initiative Number: RFA DK-05-015 and RFA DK-05-016
• Applications due: March 15, 2006
• Objective: To develop new approaches, through small business innovation research and technology transfer, to prevent, treat, monitor, and cure type 1 diabetes and its macro- and micro-vascular complications.

Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions

• Initiative Number: RFA HL-06-007
• Applications due: February 15, 2006
• Objective: To test the effectiveness in routine clinical practice of interventions for weight loss in obese patients who have other cardiovascular risk factors such as hypertension, dyslipidemia, and diabetes.

Need More Information?

We are always interested in receiving comments and suggestions from the community. If you or your organizations have questions for me or for the Institute, please contact me at nabele@nhlbi.nih.gov or Dr. Carl Roth at rothc@nhlbi.nih.gov.

For information on specific issues, the following contacts may be helpful:

For health related questions and publications, please contact the trained information specialists at the NHLBI Information Center (NHLBIinfo@nhlbi.nih.gov) or write to the Information Center at P.O. Box 30105, Bethesda, MD 20824-0105.

For communications pertaining to NHLBI policies and priorities, contact the NHLBI Office of Public Liaison, (nhlbi.listens@nih.gov).

For additional information regarding NHLBI events, consult the references provided or NHLBI Calendar. Most other NIH Institutes and Centers also maintain calendars on their Web sites. Links to their Web pages are at NIH Institutes, Centers, and Offices.

For Web related matters pertaining to the online version of the FYI from the NHLBI, contact the FYI from the NHLBI's Web Editor.